Clinicopathological and Survival Outcomes of Well-Differentiated Thyroid Carcinoma Undergoing Dedifferentiation: A Retrospective Study from FUSCC
- PMID: 29951093
- PMCID: PMC5987325
- DOI: 10.1155/2018/2383715
Clinicopathological and Survival Outcomes of Well-Differentiated Thyroid Carcinoma Undergoing Dedifferentiation: A Retrospective Study from FUSCC
Abstract
Background: Recently, several studies have reported that dedifferentiation occurs in fatal well-differentiated thyroid cancer (WDTC) cases. This study aimed at investigating the clinicopathological characteristics of WDTC undergoing dedifferentiation.
Methods: A total of 63 WDTC patients harboring dedifferentiated phenotype were enrolled in the study. The Kaplan-Meier method and Cox regression analysis were used to perform survival analyses. Harrell index of concordance (C-index) and Akaike information criterion (AIC) were calculated to compare the predictive value for prognosis among several prognostic classification systems.
Results: The median cause-specific survival (CSS) of patients was 138 months, with the CSS rate of 64.0% and 53.3% at 5 and 10 years, respectively. Presence of the anaplastic thyroid cancer (ATC) phenotype significantly increased the risk of poor CSS (P = 0.033), and age was the only independent risk factor for disease progression (P = 0.015). The C-index and AIC of the age, grade, extent, size (AGES) prognostic classification system for the CSS were 0.723 and 59.937, respectively.
Conclusions: The presence of dedifferentiated phenotypes can be responsible for the poor outcomes in WDTC patients. The AGES system demonstrates to be an optimal prognostic system for WDTC undergoing dedifferentiation.
Figures
Similar articles
-
Identifying the most appropriate age threshold for TNM stage grouping of well-differentiated thyroid cancer.Eur J Surg Oncol. 2015 Aug;41(8):1028-32. doi: 10.1016/j.ejso.2015.04.014. Epub 2015 May 7. Eur J Surg Oncol. 2015. PMID: 25986855
-
The prognostic value of lymph node metastasis and the eighth edition of AJCC for patients with anaplastic thyroid cancer.Clin Endocrinol (Oxf). 2021 Sep;95(3):498-507. doi: 10.1111/cen.14482. Epub 2021 May 3. Clin Endocrinol (Oxf). 2021. PMID: 33864292 Free PMC article.
-
Management and outcome of recurrent well-differentiated thyroid carcinoma.Arch Otolaryngol Head Neck Surg. 2004 Jul;130(7):819-24. doi: 10.1001/archotol.130.7.819. Arch Otolaryngol Head Neck Surg. 2004. PMID: 15262757
-
Prognostic markers in well differentiated papillary and follicular thyroid cancer (WDTC).Eur J Surg Oncol. 2018 Mar;44(3):286-296. doi: 10.1016/j.ejso.2017.07.013. Epub 2017 Aug 3. Eur J Surg Oncol. 2018. PMID: 28801060 Review.
-
Anaplastic thyroid cancer: prevalence, diagnosis and treatment.Minerva Endocrinol. 2008 Dec;33(4):341-57. Minerva Endocrinol. 2008. PMID: 18923370 Review.
Cited by
-
Primary small cell thyroid carcinoma combined with poorly differentiated thyroid carcinoma, evidence for a common origin: A case report.Oncol Lett. 2023 Apr 18;25(6):233. doi: 10.3892/ol.2023.13819. eCollection 2023 Jun. Oncol Lett. 2023. PMID: 37153036 Free PMC article.
-
MMP1 acts as a potential regulator of tumor progression and dedifferentiation in papillary thyroid cancer.Front Oncol. 2022 Nov 21;12:1030590. doi: 10.3389/fonc.2022.1030590. eCollection 2022. Front Oncol. 2022. PMID: 36479070 Free PMC article.
-
Enhancement of nanoparticle-mediated double suicide gene expression driven by 'E9-hTERT promoter' switch in dedifferentiated thyroid cancer cells.Bioengineered. 2021 Dec;12(1):6572-6578. doi: 10.1080/21655979.2021.1974648. Bioengineered. 2021. PMID: 34506254 Free PMC article.
-
Identification of Key Functional Gene Signatures Indicative of Dedifferentiation in Papillary Thyroid Cancer.Front Oncol. 2021 Apr 28;11:641851. doi: 10.3389/fonc.2021.641851. eCollection 2021. Front Oncol. 2021. PMID: 33996555 Free PMC article.
-
Cancer-Associated Fibroblasts Positively Correlate with Dedifferentiation and Aggressiveness of Thyroid Cancer.Onco Targets Ther. 2021 Feb 22;14:1205-1217. doi: 10.2147/OTT.S294725. eCollection 2021. Onco Targets Ther. 2021. PMID: 33654411 Free PMC article.
References
-
- Haugen B. R., Alexander E. K., Bible K. C., et al. 2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26(1):1–133. doi: 10.1089/thy.2015.0020. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
